Find consortia

Results Download Results in Excel (.XLS)


Consortium title & disease focus Tool Development

Tools

Biomarker Research

Biomarker

Basic Research

Basic

Data-Sharing
Enabler

Data

Product Development

Products

1000 Genomes Project
Tuberculosis
A GABRIEL Consortium Large-Scale Genome-Wide Association Study of Asthma
Asthma
Accelerating Medicines Partnership - Alzheimer's
Alzheimer's Disease
Accelerating Medicines Partnership—Autoimmune Diseases (Rheumatoid Arthritis & Lupus)
Arthritis, Lupus
Accelerating Medicines Partnership—Diabetes
Type 2 Diabetes
Addario Lung Cancer Consortium
Lung Cancer
AddNeuroMed
Alzheimer's Disease
Alzheimer’s Disease Genetics Consortium (ADGC)
Alzheimer's Disease
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Alzheimer's Disease
Biomarker for Cardiovascular Risk Assessment in Europe (BiomarCaRE)
Cardiovascular
Biomarkers Across Neurodegenerative Diseases (BAND)
Alzheimer's Disease, Parkinson's Disease
Biomarkers of Anti-TNF Treatment Efficacy in Rheumatoid Arthritis–Unresponsive Populations (BATTER-UP)
Rheumatoid Arthritis
BIOSAPIENS Network of Excellence
Bloodomics
Cardiovascular
Breast Cancer Somatic Genetics Study (BASIS)
Oncology
Canadian Pediatric Cancer Genome Consortium (CPCGC)
Oncology
Cancer Genomics of the Kidney (CAGEKID)
Oncology
CF Biomarker Consortium
CFTR 3D-Structure Consortium
cystic fibrosis
Childrens Brain Tumor Tissue Consortium (CBTTC)
Child Brain Cancer
Chronic Graft Versus Host Disease (cGVHD) Consortium
Immune Related Disorders After Allogenic Hematopoietic Cell Tran
Circulating Cells
Atherosclerosis
Colon Therapy Research Consortium (COLTHERES)
Oncology
CommonMind Consortium
Bipolar Disorder, Schizophrenia
COPD Biomarker Qualification Consortium (CBQC)
Copd
COPDMAP
Copd
Critical Path Institute (C-Path)
Decrease Colorectal Cancer Death (DeCoDe)
Oncology
Development of novel treatment strategies based on knowledge of cellular dysfunction in diabetes (BetaBat)
Diabetes
Development of Tools (and Prediction Rules) to Time and Select Therapy in Treatment of Preclinical, Early and Established Rheumatoid Arthritis: Creating Enhanced Remedy (TRACER)
Arthritis
Diabetes Genetics Replication and Meta-Analysis (DIAGRAM) Consortium
Type 2 Diabetes
Diabetes Research on Patient Stratification (DIRECT)
Type 2 Diabetes
Dystonia Coalition
Blepherospasm, Cervical Dystonia, Craniofacial Dystonia...
eagle-i Consortium
EURenOmics
Rare kidney disease
European Network for Genetic and Genomic Epidemiology (ENGAGE)
European Project on Mendelian Forms of Parkinson’s Disease (MEFOPA)
Parkinson's Disease
GeneQol
Genetic Association Information Network (GAIN)
Genome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancer (RESPONSIFY)
Oncology
Gliogene Consortium
Oncology
High Throughput Proteomics Systems for Accelerated Profiling of Putative Plasma Biomarkers
Cancers
IMIDIA
Diabetes
Inflammatory Bowel Disease Biomarkers Consortium (IBD BIOM)
Irritable Bowel Disease
International Cancer Genome Consortium (ICGC)
Oncology
International Inflammatory Bowel Disease Genetics Consortium (IIBDGC)
Irritable Bowel Disease
International Multiple Sclerosis Genetics (IMSG) Consortium
Multiple Sclerosis
Lung Genomics Research Consortium (LGRC)
Chronic obstructive pulmonary disease
Markers for Sub-Clinical Cardiovascular Risk Assessment (EU-MASCARA)
Cardiovascular
Maximising Therapeutic Utility for Rheumatoid Arthritis (MATURA) Consortium
Arthritis
Medulloblastoma Advanced Genomics International Consortium (MAGIC)
Oncology
MetaHIT
Obesity
Methods for systematic next generation oncology biomarker development (OncoTrack)
Oncology
Monitoring Innate Immunity in Arthritis and Mucosal Inflammation (MIAMI)
Arthritis
MUGEN
Immunological Diseases
Multiple Myeloma Research Foundation CoMMPass Study
Multiple Myeloma
National Lung Matrix Trial (NLM)
Oncology
Neoadjuvant Drug Treatment for Breast Cancer Response Prediction and Response Monitoring (Breast CARE)
Oncology
NeurOmics
Ataxia, Congenital muscular dystrophy, Congenital myasthenic syndrome...
New York Structural Genomics Research Consortium (NYSGRC)
P1vital CNS Experimental Medicine Consortium
Depression, Schizophrenia
Parkinson’s Progressive Marker Initiative (PPMI)
Parkinson's Disease
PharmaCog
Alzheimer's Disease
Placebo Data Analysis in Alzheimer’s Diseases/Mild Cognitive Impairment
Alzheimer's Disease
Polycystic Kidney Disease Outcomes Consortium
Polycystic Kidney Disease
PRECISESADS
Autoimmune Diseases
PREDICCt
Type 2 Diabetes
Prostate Cancer Molecular Medicine (PCMM)
Oncology
PROteomics SPECification in Time and Space
Psychiatric Genomics Consortium (PGC)
Anorexia, Autism, Bipolar Disorder...
Rett Syndrome, MECP2 Duplication, and Rett-Related Disorders (RTT) Consortium
Rett Syndrome
Sampling and Biomarker OPtimization and Harmonization In ALS and other motor neuron diseases (SOPHIA)
Als
Surrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT)
Diabetes
Systems Biology towards novel chronic kidney disease diagnosis and treatment (SYSKID)
Chronic Kidney Disease
Target-Melanoma: Molecular Dissection of Melanoma Progression: An Integrated Pan-European Approach
Melanoma
The development of new diagnostic tests, new tools and non-invasive methods for the prevention, early diagnosis and monitoring for haematopoietic stem cell transplantation (STEMDIAGNOSTICS)
Oncology
The Personal Genome Sequencing Outcomes (PeopleSeq) Consortium
The Viral Hemorrhagic Fever Consortium
Viral Hemorrhagic Fever, Lassa Fever, Ebola
TRanslational Initiative on Unique and novel strategies for Management of Patients with Heart failure (TRIUMPH)
Heart Failure
Translational Research in Europe — Applied Technologies for Osteoarthritis (TREAT-OA)
Arthritis
Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES)
Diabetes
UK Dementias Research Platform
Dementia
Unbiased BIOmarkers in PREDiction of respiratory disease outcomes
Asthma
Wellcome Trust Case Control Consortium (WTCCC)

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.